Nature
Jaw-dropping patient videos and miraculous testimonials ignited a frenzy in China over a technique that aims to improve drainage from the brain. Now it is entering trials worldwide.
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.
This neurologist is leading clinical efforts to treat the devastating brain disease.
Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.
The Department of Defense is continuing to bankroll projects to develop vaccines against deadly pathogens.
Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.
‘Directed’ evolution in the laboratory creates an editing tool that outperforms classic CRISPR systems.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.
3D structure of the tongue’s sweet-sensing protein could guide future food designs.